Pediatrics
Showing 611-620 of 856 Results
-
Benjamin Pinsky
Professor of Pathology, of Medicine (Infectious Diseases) and, by courtesy, of Pediatrics (Infectious Diseases)
Current Research and Scholarly InterestsDevelopment and application of molecular assays for the diagnosis and management of infectious diseases.
-
Terry Platchek
Clinical Professor, Pediatrics
Clinical Professor, Emergency Medicine
Clinical Professor (By courtesy), Medicine - Primary Care and Population Health
Clinical Professor, Emergency MedicineCurrent Research and Scholarly InterestsDr. Platchek's research interest focuses on improving value in healthcare delivery using healthcare model design thinking and a "Lean" business strategy. Dr. Platchek is also interested in effective methods for engaging clinicians in systems-based clinical improvement efforts.
-
Celeste Poe, Ph.D., PMH-C
Clinical Assistant Professor, Psychiatry and Behavioral Sciences - Child & Adolescent Psychiatry and Child Development
Clinical Assistant Professor (By courtesy), PediatricsBioDr. Celeste Poe is a licensed clinical psychologist with a certification in perinatal mental health. She completed her residency and fellowship training at the Yale Child Study Center. She received her Ph.D. from Palo Alto University, her master’s degree from Pepperdine University and she is a proud HBCU alumni of Xavier University of Louisiana where she received her bachelor’s degree.
Dr. Poe is a Clinical Assistant Professor and Attending NICU and Perinatal Psychologist at Stanford University School of Medicine. She is the program director of the maternal & infant critical care mental health services at Lucile Packard Children's Hospital where she provides psychological consultation and psychotherapy to parents requiring hospitalization due to high risk pregnancies and parents of infants hospitalized in the NICU. Dr. Poe’s clinical specialties include perinatal and infant mental health as well as maternal-infant critical care with a focus on child and caregiver trauma, grief, and bereavement. Her research focuses on Black perinatal mental health and mental health equity, infant and parent mental health in medical settings, and intergenerational trauma. Dr. Poe was a Zero to Three Fellow and currently serves as Co-Chair of the National Network of NICU Psychologists. In 2026 she was appointed to the American Psychological Association's committee on Children Youth and families.
Dr. Poe also holds a community faculty appointment as an Assistant Clinical Professor at the Yale Child Study Center where she works on the Grief-Sensitive Healthcare Project which aims to enhance healthcare providers’ capacities to meet the needs of grieving families. -
Matthew Porteus
Sutardja Chuk Professor of Definitive and Curative Medicine
BioDr. Porteus was raised in California and was a local graduate of Gunn High School before completing A.B. degree in “History and Science” at Harvard University where he graduated Magna Cum Laude and wrote an thesis entitled “Safe or Dangerous Chimeras: The recombinant DNA controversy as a conflict between differing socially constructed interpretations of recombinant DNA technology.” He then returned to the area and completed his combined MD, PhD at Stanford Medical School with his PhD focused on understanding the molecular basis of mammalian forebrain development with his PhD thesis entitled “Isolation and Characterization of TES-1/DLX-2: A Novel Homeobox Gene Expressed During Mammalian Forebrain Development.” After completion of his dual degree program, he was an intern and resident in Pediatrics at Boston Children’s Hospital and then completed his Pediatric Hematology/Oncology fellowship in the combined Boston Chidlren’s Hospital/Dana Farber Cancer Institute program. For his fellowship and post-doctoral research he worked with Dr. David Baltimore at MIT and CalTech where he began his studies in developing homologous recombination as a strategy to correct disease causing mutations in stem cells as definitive and curative therapy for children with genetic diseases of the blood, particularly sickle cell disease. Following his training with Dr. Baltimore, he took an independent faculty position at UT Southwestern in the Departments of Pediatrics and Biochemistry before again returning to Stanford in 2010 as an Associate Professor. During this time his work has been the first to demonstrate that gene correction could be achieved in human cells at frequencies that were high enough to potentially cure patients and is considered one of the pioneers and founders of the field of genome editing—a field that now encompasses thousands of labs and several new companies throughout the world. His research program continues to focus on developing genome editing by homologous recombination as curative therapy for children with genetic diseases but also has interests in the clonal dynamics of heterogeneous populations and the use of genome editing to better understand diseases that affect children including infant leukemias and genetic diseases that affect the muscle. Clinically, Dr. Porteus attends at the Lucille Packard Children’s Hospital where he takes care of pediatric patients undergoing hematopoietic stem cell transplantation.
